Losartan-induced hepatotoxicity

被引：20

作者：

Bosch, X

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1997年 / 278卷 / 19期

关键词：

D O I：

10.1001/jama.278.19.1572

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1572 / 1572

页数：1

相关论文

共 4 条

[1] LOSARTAN IN HEART-FAILURE - HEMODYNAMIC-EFFECTS AND TOLERABILITY
CROZIER, I
IKRAM, H
AWAN, N
CLELAND, J
STEPHEN, N
DICKSTEIN, K
FREY, M
YOUNG, J
KLINGER, G
MAKRIS, L
RUCINSKA, E
[J]. CIRCULATION, 1995, 91 (03) : 691 - 697
[2] HEMODYNAMIC AND NEUROHORMONAL EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST LOSARTAN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
GOTTLIEB, SS
DICKSTEIN, K
FLECK, E
KOSTIS, J
LEVINE, TB
LEJEMTEL, T
DEKOCK, M
[J]. CIRCULATION, 1993, 88 (04) : 1602 - 1609
[3] MEDICAL PROGRESS - DRUG-INDUCED HEPATOTOXICITY
LEE, WM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (17) : 1118 - 1127
[4] Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Pitt, B
Segal, R
Martinez, FA
Meurers, G
Cowley, AJ
Thomas, I
Deedwania, PC
Ney, DE
Snavely, DB
Chang, PI
[J]. LANCET, 1997, 349 (9054) : 747 - 752